Market Tracker

09/30 11:16am ET

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

13.64
BATS BZX Real-Time Price
As of 11:16am ET
 -0.07 / -0.51%
Today’s Change
4.37
Today|||52-Week Range
14.26
+118.24%
Year-to-Date
ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan
10:54am / Zacks.com - Paid Partner Content
Ardelyx (ARDX) Worth Watching: Stock Rises 6.1% in Session
Sep 28 / Zacks.com - Paid Partner Content
Biotech Stock Mailbag: Dynavax, Puma, Ariad
7:06am / TheStreet.com - Paid Partner Content
Dipexium Pharmaceuticals (DPRX) Worth a Look: Stock Up 8.8%
Sep 28 / Zacks.com - Paid Partner Content
AcelRx (ACRX) Initiates Phase III IAP312 Study on Zalviso
Sep 28 / Zacks.com - Paid Partner Content
Ariad Pharmaceuticals (ARIA) Stock Climbs, Coverage Initiated at Leerink
Sep 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close13.71
Today’s open13.75
Day’s range12.95 - 13.77
Volume579,617
Average volume (3 months)5,288,319
Market cap$2.6B
Dividend yield--
Data as of 11:16am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+92.50%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+12.70%
P/E ratioNM
Price/Sales9.93
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.02+1.82%
BLUEbluebird bio Inc+2.21+3.33%
RDUSRadius Health Inc-0.55-1.00%
NKTRNektar Therapeutics+0.30+1.77%
Data as of 11:16am ET, 09/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$118.8M
Annual profit (last year)-$231.2M
Net profit margin-194.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paris Panayiotopoulos
Chief Financial Officer, Treasurer &
Executive VP
Manmeet Singh Soni
Corporate headquarters
Cambridge, Massachusetts

Forecasts